Ztnfr14, a tumor necrosis factor receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 24, 2009
Grant Date -
Nov 17, 2005
app pub date -
Oct 18, 2004
filing date -
Oct 16, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel tumor necrosis factor receptor (TNFR) polypeptides, polynucleotides encoding the polypeptides, antibodies and related compositions and methods are disclosed. The polypeptides may be used for detecting ligand, as well as agonists and antagonists. The polypeptides, polynucleotides and antibodies may also be used in methods that modulate tumor growth, metastasis, and immunity such as separating resting from stimulated immune cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully